1 – 10 of 186
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Cerebrospinal fluid biomarker levels: Total tau and phosphorylated tau as markers for rate of progression in Alzheimer’s disease.
- Neurofilament light and tau as blood biomarkers for sports-related concussion
- No association of salivary total tau concentration with Alzheimer's disease
- Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients
- Comparing 18 F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
- Update on biomarkers for amyloid pathology in Alzheimer's disease
- Apolipoprotein E genotypes and longevity across dementia disorders
- Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease
- Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation : A 22-year follow-up study
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression : A study of fully automated immunoassays in BioFINDER and ADNI cohorts